Page 5 - Morphosys Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Morphosys daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Morphosys Daily Today - Breaking & Trending Today

MorphoSys (NASDAQ:MOR) Stock Rating Reaffirmed by Leerink Partnrs

Leerink Partnrs reiterated their market perform rating on shares of MorphoSys (NASDAQ:MOR – Free Report) in a research note published on Wednesday morning, PriceTargets.com reports. Leerink Partnrs also issued estimates for MorphoSys’ FY2026 earnings at ($0.78) EPS. A number of other research analysts have also recently weighed in on MOR. Morgan Stanley raised MorphoSys from […] ....

United States , Leerink Partnrs , Morgan Stanley , Blackrock Inc , Virtu Financial , Qube Research Technologies Ltd , Jpmorgan Chase Co , Goldman Sachs Group , Free Report , Get Free Report , Technologies Ltd , Morphosys Daily , Nasdaq Mor , Reiterated Rating ,

Leerink Partnrs Reiterates "Market Perform" Rating for MorphoSys (NASDAQ:MOR)

Leerink Partnrs reissued their market perform rating on shares of MorphoSys (NASDAQ:MOR – Free Report) in a research report report published on Wednesday morning, PriceTargets.com reports. Leerink Partnrs also issued estimates for MorphoSys’ FY2026 earnings at ($0.78) EPS. Other research analysts have also issued research reports about the company. The Goldman Sachs Group cut their […] ....

United States , Leerink Partnrs , Morgan Stanley , Citadel Advisors , Virtu Financial , Jpmorgan Chase Co , Optiver Holding , Goldman Sachs Group , T Rowe Price Investment Management Inc , Free Report , Get Free Report , Price Investment Management , Morphosys Daily , Nasdaq Mor , Reiterated Rating ,

MorphoSys (NASDAQ:MOR) Rating Reiterated by Leerink Partnrs

MorphoSys (NASDAQ:MOR – Get Free Report)‘s stock had its “market perform” rating reissued by analysts at Leerink Partnrs in a research note issued to investors on Wednesday, PriceTargets.com reports. Leerink Partnrs also issued estimates for MorphoSys’ FY2026 earnings at ($0.78) EPS. A number of other equities research analysts have also weighed in on the stock. […] ....

United States , Leerink Partnrs , Morgan Stanley , Envestnet Asset Management Inc , Qube Research Technologies Ltd , Virtu Financial , Goldman Sachs Group , Morphosys Company Profile , Jpmorgan Chase Co , Get Free Report , Technologies Ltd , Envestnet Asset Management , Morphosys Daily , Nasdaq Mor , Reiterated Rating ,

Analysts Set MorphoSys AG (NASDAQ:MOR) Target Price at $12.49

Shares of MorphoSys AG (NASDAQ:MOR – Get Free Report) have received an average recommendation of “Moderate Buy” from the eight brokerages that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and five have given a buy rating to the […] ....

United States , Qube Research Technologies Ltd , Goldman Sachs Group , Virtu Financial , Blackrock Inc , Morphosys Company Profile , Morgan Stanley , Get Free Report , Technologies Ltd , Get Free , Morphosys Daily , Nasdaq Mor ,

MorphoSys AG (NASDAQ:MOR) Receives Average Recommendation of "Moderate Buy" from Brokerages

Shares of MorphoSys AG (NASDAQ:MOR – Get Free Report) have earned an average rating of “Moderate Buy” from the eight research firms that are presently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, two have given a hold rating and five have issued a buy rating on […] ....

United States , Goldman Sachs Group , Morgan Stanley , Marshall Wace , Morphosys Company Profile , T Rowe Price Investment Management Inc , Optiver Holding , Get Free Report , Rowe Price Investment Management , Global Management , Get Free , Morphosys Daily , Nasdaq Mor ,